Edition:
United Kingdom

Dermira Inc (DERM.OQ)

DERM.OQ on NASDAQ Stock Exchange Global Select Market

8.63USD
23 Aug 2019
Change (% chg)

$-0.35 (-3.90%)
Prev Close
$8.98
Open
$8.92
Day's High
$9.26
Day's Low
$8.62
Volume
170,288
Avg. Vol
241,008
52-wk High
$15.47
52-wk Low
$6.00

About

Dermira, Inc. is a biopharmaceutical company. The Company is focused on the development of therapeutic solutions in medical dermatology to treat skin conditions, such as hyperhidrosis, psoriasis and acne. Its portfolio includes three late-stage product candidates: Cimzia (certolizumab pegol), glycopyrronium tosylate and... (more)

Overall

Beta: 1.30
Market Cap(Mil.): $455.64
Shares Outstanding(Mil.): 53.67
Dividend: --
Yield (%): --

Financials

  DERM.OQ Industry Sector
P/E (TTM): -- 98.31 33.85
EPS (TTM): -5.34 -- --
ROI: -56.20 7.52 12.69
ROE: -224.35 7.94 17.13

BRIEF-Dermira Inc Entered Into First Amendment To License Agreement With Roche

* DERMIRA INC - ENTERED INTO FIRST AMENDMENT TO LICENSE AGREEMENT WITH ROCHE

28 Feb 2019
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates